Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE: Envarsus XR vs Immediate Release Tacrolimus in Kidney Transplant Recipients
NCT03979365Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2019
- Primary completion
- Mar 2022
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Mayo Clinic. Started Jul 2019; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03979365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979365.